Analyst Reco. Moderna, Inc.

Equities

MRNA

US60770K1079

Real-time Estimate Cboe BZX Other stock markets 12:03:51 2024-06-10 pm EDT			5-day change	1st Jan Change
147.6 ^USD	-2.24%		-0.20%	+48.35%

05:56pm	Top Midday Stories: Elliott Amasses $2 Billion Stake in Southwest; SCOTUS to Review Meta Investor Data-Harvesting Suit; Blackstone Competes Tropical Smoothie Acquisition	MT
03:18pm	Moderna's Combination Flu, COVID-19 Shot Triggers High Immune Responses in Late-stage Study	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jefferies Adjusts Price Target on Moderna to $180 From $155, Keeps Buy Rating	Jun. 07	MT
RBC Raises Moderna's PT to $160 From $135 Amid RSV Vaccine Approval From US FDA, Keeps Outperform Rating	Jun. 03	MT
RBC Raises Price Target on Moderna to $160 From $135 Amid RSV Vaccine Approval From FDA, Keeps Outperform Rating	Jun. 03	MT
MODERNA : Oddo BHF raises its target price on the stock	Jun. 03	CF
ANALYSTS RECOMMENDATIONS : Best Buy, Dell Technologies, Moderna, AMD, National Grid...	Jun. 03
Moderna Insider Sold Shares Worth $2,901,585, According to a Recent SEC Filing	Jun. 03	MT
RBC Raises Moderna's Price Target to $160 From $135	May. 31	MT
Moderna Insider Sold Shares Worth $1,909,863, According to a Recent SEC Filing	May. 20	MT
Moderna Insider Sold Shares Worth $1,912,350, According to a Recent SEC Filing	May. 17	MT
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program	May. 17	MT
ANALYST RECOMMENDATIONS : Nike, Roblox, Starbucks, Walmart, Deckers Outdoor...	May. 14
Evercore ISI Initiates Moderna With In Line Rating, $120 Price Target	May. 14	MT
Moderna Insider Sold Shares Worth $1,825,220, According to a Recent SEC Filing	May. 13	MT
Deutsche Bank Raises Moderna's Price Target to $85 From $70	May. 09	MT
UBS Adjusts Moderna Price Target to $151 From $143, Maintains Buy Rating	May. 07	MT
Moderna Insider Sold Shares Worth $1,663,855, According to a Recent SEC Filing	May. 06	MT
Jefferies Adjusts Price Target on Moderna to $155 From $125	May. 03	MT
Oppenheimer Adjusts Price Target on Moderna to $163 From $142	May. 03	MT
Goldman Sachs Adjusts Price Target on Moderna to $204 From $206	May. 03	MT
Leerink Adjusts Price Target on Moderna to $60 From $59	May. 03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Moderna, Inc. prepares for the post-Covid era

March 25, 2024 at 10:24 am EDT

Stéphane Bancel, CEO of Moderna: Restoring confidence in the vaccines sector

January 16, 2024 at 03:31 pm EST